Local effects of antimuscarinics
- Authors
- Masuda, Hitoshi; Kim, Yong-Tae; Tyagi, Shachi; Chancellor, Michael B.; de Miguel, Fernando; Yoshimura, Naoki
- Issue Date
- Nov-2006
- Publisher
- W B SAUNDERS CO-ELSEVIER INC
- Citation
- UROLOGIC CLINICS OF NORTH AMERICA, v.33, no.4, pp.511 - +
- Indexed
- SCIE
SCOPUS
- Journal Title
- UROLOGIC CLINICS OF NORTH AMERICA
- Volume
- 33
- Number
- 4
- Start Page
- 511
- End Page
- +
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180766
- DOI
- 10.1016/j.ucl.2006.06.011
- ISSN
- 0094-0143
- Abstract
- Overactive bladder (OAB) syndrome has been estimated to occur in nearly 17% of the population. The most common drug treatments for OAB are antimuscarinic agents that act to increase bladder capacity and decrease the urge to urinate during the storage phase. An increasing number of studies have focused on the role and mechanism of muscarinic acetylcholine receptors for the regulation of afferent activity during urine storage. Interactions between muscarinic receptors in the urothelium, afferent nerves, or myofibroblasts and locally released acetylcholine might be involved in the emergence of detrusor overactivity and OAB. Therefore, antimuscarinic agents may be effective in treating OAB not only by suppression of muscarinic receptor-mediated detrusor muscle contractions but also by modulation of muscarinic receptor-bladder afferent interactions.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 비뇨의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180766)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.